Skip to main content
SpringerLink
Log in

Non-steroidal Anti-inflammatory Drugs

  • Chapter
Book cover Intraocular Inflammation

Abstract

Non-steroidal anti-inflammatory drugs (NSAIDs) are the mainstay of treatment for mild inflammatory joint disease, and hence there is hope that these drugs should be beneficial, either locally or systemically, in the management of inflammatory eye disease. The alternative management options are steroids, which with all their accompanying side effects are not ideal. Hence, it would be of great help to patients if NSAIDs were efficacious in these conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Antman EM, Bennett JS, Daugherty A et al (2007) Use of nonsteroidal antiinflammatory drugs an update for clinicians a scientific statement from the American Heart Association. Circulation 115:1634–1642

    Article  PubMed  Google Scholar 

  2. Bauer AM, Fiehn C, Becker M (2005) Celecoxib, a selective inhibitor of cyclooxygenase 2 for therapy of diffuse anterior scleritis. Am J Ophthalmol 139:1086–1089

    Article  CAS  PubMed  Google Scholar 

  3. Bucolo C, Spadaro A (1997) Pharmacological evaluation of anti-inflammatory pyrrole-acetic acid derivative eye drops. J Ocul Pharmacol Ther 13:353–361

    Article  CAS  PubMed  Google Scholar 

  4. Colin J (2007) The role of NSAIDs in the management of postoperative ophthalmic inflammation. Drugs 67:1291–1308

    Article  CAS  PubMed  Google Scholar 

  5. Demco TA, Sutton H, Demco CJ et al (1997) Topical diclofenac sodium compared with prednisolone acetate after phacoemulsification-lens implant surgery. Eur J Ophthalmol 7:236–240

    CAS  PubMed  Google Scholar 

  6. Diestelhorst M, Schmidl B, Konen W et al (1996) Efficacy and tolerance of diclofenac sodium 0.1 %, flurbiprofen 0.03 %, and indomethacin 1.0 % in controlling postoperative inflammation. J Cataract Refract Surg 22:788–793

    Article  PubMed  Google Scholar 

  7. Dunne JA, Jacobs N, Morrison A et al (1985) Efficacy in anterior uveitis of two known steroids and topical tolmetin. Br J Ophthalmol 69:120–125

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. El-Harazi SM, Ruiz RS, Feldman RM et al (1998) A randomized double-masked trial comparing ketorolac tromethamine 0.5 %, diclofenac sodium 0.1 % and prednisolone acetate 1 % in reducing post-phacoemulsification flare and cells. Ophthalmic Surg Lasers 29:539–544

    CAS  PubMed  Google Scholar 

  9. Flach AJ (2002) Topical nonsteroidal antiinflammatory drugs in ophthalmology. Int Ophthalmol Clin 42:1–11

    Article  PubMed  Google Scholar 

  10. Flach AJ, Dolan BJ, Irvine AR (1987) Effectiveness of ketorolac tromethamine 0.5 % ophthalmic solution for chronic aphakic and pseudophakic cystoid macular edema. Am J Ophthalmol 103:479–486

    Article  CAS  PubMed  Google Scholar 

  11. Flach AJ, Lavelle CJ, Olander KW et al (1988) The effect of ketorolac 0.5 % solution in reducing post-surgical inflammation following ECCE with IOL. Ophthalmology 95:1279–1284

    Article  CAS  PubMed  Google Scholar 

  12. Frishman WH (2002) Effects of nonsteroidal anti-inflammatory drug therapy on blood pressure and peripheral edema. Am J Cardiol 89:18D–25D

    Article  CAS  PubMed  Google Scholar 

  13. Gamache DA, Graff G, Milton TB et al (2000) Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: I. Assessment of anti-inflammatory efficacy. Inflammation 24:357–370

    Article  CAS  PubMed  Google Scholar 

  14. Guex-Crosier Y (1999) The pathogenesis and clinical presentation of macular edema in inflammatory diseases. Doc Ophthalmol 97:297–309

    Article  CAS  PubMed  Google Scholar 

  15. Hakin KN, Watson PG (1991) Systemic associations of scleritis. Int Ophthalmol Clin 31:111–129

    Article  CAS  PubMed  Google Scholar 

  16. Hayasaka Y, Hayasaka S, Zhang XY et al (2003) Effects of topical corticosteroids and nonsteroidal anti-inflammatory drugs on prostaglandins e2-induced aqueous flare elevation in pigmented rabbits. Ophthalmic Res 35:341–344

    Article  CAS  PubMed  Google Scholar 

  17. Heier J, Cheetham JK, Degryse R et al (1999) Ketorolac tromethamine 0.5 % ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial. Am J Ophthalmol 127:253–259

    Article  CAS  PubMed  Google Scholar 

  18. Hooper L, Brown TJ, Elliott R et al (2004) The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review. BMJ 329:948–958

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Jabs DA, Mudun A, Dunn JP et al (2000) Episcleritis and scleritis: clinical features and treatment results. Am J Ophthal 130:469–476

    Article  CAS  PubMed  Google Scholar 

  20. Kapin MA, Yanni JM, Brady MT et al (2003) Inflammation-mediated retinal edema in the rabbit is inhibited by topical nepafenac. Inflammation 27:281–291

    Article  CAS  PubMed  Google Scholar 

  21. Khosravi E, Elena PP, Hariton C (1995) Allergic conjunctivitis and uveitis models: reappraisal with some marketed drugs. Inflamm Res 44:47–54

    Article  CAS  PubMed  Google Scholar 

  22. Lane SS, Modi SS, Lehmann RP et al (2007) Nepafenac ophthalmic suspension 0.1 % for the prevention and treatment of ocular inflammation associated with cataract surgery. J Cataract Refract Surg 33:53–58

    Article  PubMed  Google Scholar 

  23. Lindstrom R, Kim T (2006) Ocular permeation and inhibition of retinal inflammation: an examination of data and expert opinion on the clinical utility of nepafenac. Curr Med Res Opin 22:397–404

    Article  CAS  PubMed  Google Scholar 

  24. Nguyen QD, Foster S (1998) Saving the vision of children with juvenile rheumatoid arthritis-associated uveitis. JAMA 280:1133–1134

    Article  CAS  PubMed  Google Scholar 

  25. Ogawa T, Sakaue T, Terai T et al (1995) Effects of bromfenac sodium, non-steroidal anti-inflammatory drug, on acute ocular inflammation. Nippon Ganka Gakkai Zasshi – Acta Societatis Ophthalmologicae Japonicae 99:406–411

    CAS  PubMed  Google Scholar 

  26. Olson NY, Lindsley CB, Godfrey WA (1988) Nonsteroidal anti-inflammatory drug therapy in chronic childhood iridocyclitis. Am J Dis Child 142:1289–1292

    CAS  PubMed  Google Scholar 

  27. Ostrov CS, Sirkin SR, Deutsch WE et al (1997) Ketorolac, prednisolone and dexamethasone for postoperative inflammation. Clin Ther 19:259–272

    Article  CAS  PubMed  Google Scholar 

  28. Papa V, Milazzo G, Santocono M et al (2001) Naproxen ophthalmic solution to manage inflammation after phacoemulsification. J Cataract Refract Surg 28:321–32724

    Article  Google Scholar 

  29. Rabiah PK, Fiscella RG, Tessler HH (1996) Intraocular penetration of periocular ketorolac and efficacy in experimental uveitis. Invest Ophthalmol Vis Sci 37:613–618

    CAS  PubMed  Google Scholar 

  30. Roberts CW (1996) Pretreatment with topical diclofenac sodium to decrease postoperative inflammation. Ophthalmology 103:636–639

    Article  CAS  PubMed  Google Scholar 

  31. Roberts CW, Brennan KM (1995) A comparison of topical diclofenac with prednisolone for postcataract inflammation. Arch Ophthalmol 113:725–727

    Article  CAS  PubMed  Google Scholar 

  32. Rojas B, Zafirakis P, Christen W et al (1999) Medical treatment of macular edema in patients with uveitis. Doc Ophthalmol 97:399–407

    Article  CAS  PubMed  Google Scholar 

  33. Rosenbaum JT, Robertson JE (1993) Recognition of posterior scleritis and its treatment with indomethacin. Retina 13:17–21

    Article  CAS  PubMed  Google Scholar 

  34. Rowland JM, Ford CJ, Della Puca RA et al (1986) Effects of topical diclofenac sodium in a rabbit model of ocular inflammation and leukotaxis. J Ocul Pharmacol 2:23–29

    Article  CAS  PubMed  Google Scholar 

  35. Sainz de la Maza M, Jabbur NS, Foster CS (1994) Severity of scleritis and episcleritis. Ophthalmology 101:389–396

    Article  CAS  PubMed  Google Scholar 

  36. Sand BB, Krogh E (1991) Topical indomethacin: a prostaglandin inhibitor, in acute anterior uveitis. A controlled clinical trial of non-steroidal versus steroid anti-inflammatory treatment. Acta Ophthalmol 69:145–148

    Article  CAS  Google Scholar 

  37. Simone JN, Pendelton RA, Jenkins JE (1999) Comparison of the efficacy and safety of ketorolac tromethamine 0.5 % and prednisolone acetate 1 % after cataract surgery. J Cataract Refract Surg 25:699–704

    Article  CAS  PubMed  Google Scholar 

  38. Sivaprasad S, Bunce C, Wormald R (2005) Non-steroidal anti-inflammatory agents for cystoid macular edema following cataract surgery: a systematic review. Br J Ophthalmol 89:1420–1422

    Google Scholar 

  39. Solomon KD, Cheetham JK, DeGryse R et al (2001) Topical ketorolac tromethamine 0.5 % ophthalmic solution in ocular inflammation after cataract surgery. Ophthalmology 108:331–337

    Article  CAS  PubMed  Google Scholar 

  40. Soukiasian SH, Foster CS, Raizman MB (1994) Treatment strategies for scleritis and uveitis associated with inflammatory bowel disease. Am J Ophthalmol 118:601–611

    Article  CAS  PubMed  Google Scholar 

  41. Spampinato S, Marino A, Bucolo C et al (1991) Effects of sodium naproxen eye drops on rabbit ocular inflammation induced by sodium arachidonate. J Ocul Pharmacol 7:125–133

    Article  CAS  PubMed  Google Scholar 

  42. Spiegel BM, Chiou CF, Ofman JJ (2005) Minimizing complications from nonsteroidal antiinflammatory drugs: cost-effectiveness of competing strategies in varying risk groups. Arthritis Rheum 53:185–197

    Article  PubMed  Google Scholar 

  43. Tilden ME, Boney RS, Goldenberg MM et al (1990) The effects of topical S(+)-ibuprofen on interleukin-1 induced ocular inflammation in a rabbit model. J Ocul Pharmacol 6:131–135

    Article  CAS  PubMed  Google Scholar 

  44. Teasley LA, Christen WG, Foster CS (2007) Oral nonsteroidal anti-inflammatory agents in the treatment of chronic or recurrent noninfectious uveitis. Contempor Ophthalmol 6:1–6

    Google Scholar 

  45. Tuft SJ, Watson PG (1991) Progression of scleral disease. Ophthalmology 98:467–471

    Article  CAS  PubMed  Google Scholar 

  46. Vickers FF, McGuigan LJB, Ford C et al (1991) The effect of diclofenac sodium ophthalmic solution on the treatment of postoperative inflammation. Invest Ophthalmol Vis Sci 32:793

    Google Scholar 

  47. Waterbury LD, Flach AJ (2004) Efficacy of low concentrations of ketorolac tromethamine in animal models of ocular inflammation. J Ocular Pharmacol Therapeut 20:345–352

    Article  CAS  Google Scholar 

  48. Waterbury LD, Flach AJ (2006) Comparison of ketorolac tromethamine, diclofenac sodium, and loteprednol etabonate in an animal model of ocular inflammation. J Ocul Pharmacol Ther 22:155–159

    Article  CAS  PubMed  Google Scholar 

  49. Waterbury LD, Silliman D, Jolas T (2006) Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium. Curr Med Res Opin 22:1133–1140

    Article  CAS  PubMed  Google Scholar 

  50. Watson PG, Hayreh SS (1976) Scleritis and episcleritis. Br J Ophthalmol 70:163–191

    Article  Google Scholar 

  51. Young BJ, Cunningham WF, Akingbehin T (1982) Double-masked controlled clinical trial of 0.5 % tolmetin versus 0.5 % prednisolone versus 0.9 % saline in acute endogenous nongranulomatous anterior uveitis. Br J Ophthalmol 66:389–391

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Guy’s & St. Thomas’ NHS Trust, London, UK

    Shouvik Saha BSc, MBBS & Elizabeth M. Graham FRCP, FRCOphth

Authors
  1. Shouvik Saha BSc, MBBS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elizabeth M. Graham FRCP, FRCOphth
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shouvik Saha BSc, MBBS .

Editor information

Editors and Affiliations

  1. Centre of Ophthalmology, University of Tuebingen, Tuebingen, Germany

    Manfred Zierhut

  2. Biomedical Research Centre, Institute of Ophthalmology, Moorfields Eyes Hospital, Department of Medical Retina, UCL, London, United Kingdom

    Carlos Pavesio

  3. School of Medicine, Department of Ophthalmology, Hokkaido University Graduate, Sapporo, Hokkaido, Japan

    Shigeaki Ohno

  4. University of Belo Horizonte, Belo Horizonte, Brazil

    Fernando Orefice

  5. USC Eye Institute, University of Southern California, Los Angeles, California, USA

    Narsing A. Rao

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Saha, S., Graham, E.M. (2016). Non-steroidal Anti-inflammatory Drugs. In: Zierhut, M., Pavesio, C., Ohno, S., Orefice, F., Rao, N. (eds) Intraocular Inflammation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-75387-2_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-75387-2_20

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-75385-8

  • Online ISBN: 978-3-540-75387-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation